Niagen Bioscience Inc NAGE Q1 2026 Earnings EPS Beats Estimates by 086 but Stock Declines 343 Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies KRNY Q1 2026 Earnings EPS Misses Estimates Amid Cautious Quarter CPSH Q1 2026 Earnings EPS Misses Estimates Stock Rises Over 28 BRBI Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges